Technologies scoping report
5
Gastric electrical stimulation
In response to an enquiry from the
West of Scotland Upper GI Surgery Unit, Department of
Oesophagogastric Surgery, Glasgow Royal Infirmary.
The following question was
scoped:
1. In patients with severe
gastroparesis refractory to pharmacological treatment, what is the
evidence for clinical and cost effectiveness of gastric electical
Stimulation (EnterraTM device) in reducing symptoms, reducing
requirement for nutritional support or hospitalisation and
improving quality of life, when compared with medical or
alternative surgical treatments.
The content of this technologies
scoping report was accurate and based upon the most up to date
evidence available at the date of first publication. Readers are
asked to consider that new trials and technologies may have emerged
since first publication and the evidence presented may no longer be
current.
Published Date: 23 March 2012
